Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
ALL
Debate: Best Therapy For ALL In First Relapse Or Disease Refractory To Standard Treatment: CAR-T
Thursday, March 24, 2022
12:05 PM – 12:20 PM
Debate Speaker(s)
Bijal Shah, MD, MS
Associate Member, Malignant Hematology
H. Lee Moffitt Cancer Center
Tampa, Florida
Learning Objectives:
Identify the molecular targets for currently available treatments for R/R ALL
Summarize key efficacy and safety data for approved therapeutic regimens for R/R ALL